$11.85
0.262.24%
At Close: -
$11.85
00.00%
After Hours: Sep 20, 4:04 PM EDT
15 minutes delayed
Bioventus reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bioventus using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $0.19 | $0.07 | 171.4 % |
Mar 2024 | 2024-05-07 | $0.07 | $-0.07 | 200.0 % |
Dec 2023 | 2024-03-12 | $0.07 | $0.02 | 250.0 % |
Sep 2023 | 2023-11-07 | $0.05 | $0.06 | -16.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $151.22M | $137.59M | 9.90 % |
Mar 2024 | 2024-05-07 | $129.46M | $118.38M | 9.36 % |
Dec 2023 | 2024-03-12 | $135.42M | $123.96M | 9.25 % |
Sep 2023 | 2023-11-07 | $120.79M | $120.34M | 0.38 % |
Bioventus (BVS) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $0.19, which beat the estimate of $0.07.
The Actual Revenue was $151.2M, which beat the estimate of $137.6M.
Browse earnings estimates, EPS, and revenue on all stocks.